Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Moodys
Boehringer Ingelheim
Merck
McKesson
Colorcon
Mallinckrodt

Last Updated: November 18, 2019

DrugPatentWatch Database Preview

Encore Dermat Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for ENCORE DERMAT, and what generic alternatives to ENCORE DERMAT drugs are available?

ENCORE DERMAT has two approved drugs.

There are ten US patents protecting ENCORE DERMAT drugs.

There are twenty patent family members on ENCORE DERMAT drugs in fifteen countries.

Summary for Encore Dermat
International Patents:20
US Patents:10
Tradenames:2
Ingredients:2
NDAs:2

Drugs and US Patents for Encore Dermat

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Encore Dermat SERNIVO betamethasone dipropionate SPRAY;TOPICAL 208079-001 Feb 5, 2016 RX Yes Yes 9,364,485   Start Trial Y   Start Trial
Encore Dermat SERNIVO betamethasone dipropionate SPRAY;TOPICAL 208079-001 Feb 5, 2016 RX Yes Yes 9,655,907   Start Trial Y   Start Trial
Encore Dermat IMPOYZ clobetasol propionate CREAM;TOPICAL 209483-001 Nov 28, 2017 RX Yes Yes 9,956,231   Start Trial Y   Start Trial
Encore Dermat IMPOYZ clobetasol propionate CREAM;TOPICAL 209483-001 Nov 28, 2017 RX Yes Yes 10,064,875   Start Trial Y   Start Trial
Encore Dermat SERNIVO betamethasone dipropionate SPRAY;TOPICAL 208079-001 Feb 5, 2016 RX Yes Yes 9,439,911   Start Trial Y   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Paragraph IV (Patent) Challenges for ENCORE DERMAT drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Topical Spray 0.05% ➤ Subscribe 2018-02-15
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
McKesson
Express Scripts
Dow
McKinsey
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.